Hook & thesis
Farmers & Merchants Bancorp (FMCB) is the kind of small regional bank that quietly delivers steady returns: record net income for 2025, a long track record of rising dividends and an enlarged share-repurchase program. At the current quote of $1349.99 the stock looks attractively priced on reported earnings and supported by buybacks and dividend discipline. For investors who want exposure to a conservatively run community bank with an income tilt and capital-return optionality, FMCB is worth a tactical long position.
My trade idea is straightforward: buy at $1349.99, size accordingly for a medium-risk allocation, place a protective stop at $1200.00, and target $1600.00 over a long-term horizon (180 trading days). That setup captures multiple positive catalysts while controlling for the real liquidity and macro risks that affect OTC regional banks.
What the company does and why the market should care
Farmers & Merchants Bancorp is a community-focused bank headquartered in Lodi, CA. Its appeal to investors is not highflying growth but consistent profitability, conservative underwriting and steady capital returns. The bank reported record annual net income of $93.6 million for 2025 (up 6% year-over-year) and reported record Q1 2026 net income of $24.1 million with diluted EPS of $35.34 (up 7.6% YoY). Diluted EPS for 2025 was $133.96 (up 10.7% YoY).
Those numbers matter because they underpin two investor-friendly policies: a long history of dividend increases and a meaningful buyback program. The bank has paid dividends for 91 consecutive years and increased them for 61 years, recently being recognized as a Dividend King. The board has pushed capital back to shareholders via a repurchase program now totaling $57.6 million. For value-minded investors, this combination of reliable earnings, dividends and buybacks creates an appealing risk-reward when the share price is reasonable.
Data-backed support for the bull case
| Metric | Value |
|---|---|
| Current price | $1349.99 |
| 2025 Net income | $93.6M |
| Q1 2026 Net income | $24.1M |
| 2025 Diluted EPS | $133.96 |
| Quarterly dividend (announced 05/12/2026) | $5.35 (effective 07/01/2026) |
| Buyback authorization | $57.6M |
Valuation looks reasonable on a simple earnings multiple: using 2025 diluted EPS of $133.96, the share price of $1349.99 implies a trailing P/E near 10.1x. The resulting annualized dividend (~$5.35 x 4 = $21.40) yields ~1.6% at the current price, which is modest but backed by a 91-year distribution history and recent increases.
Technicals and liquidity
Technically the stock is in an uptrend: the 10-day SMA (~$1319), 20-day SMA (~$1307) and 50-day SMA (~$1216) slope higher and today's price sits above those averages. Short-term momentum indicators are stretched; RSI is near 69.4 and MACD histogram shows a slight negative reading, so short-term consolidation is possible. Volume is thin on the OTC listing (today's total volume 66 shares), which means moves can be exaggerated and stops should be sized carefully.
Catalysts (what could drive the trade higher)
- Continued earnings growth: record net income and sequential quarterly growth would validate the valuation multiple and justify a re-rating.
- Dividend increases and cash returns: the announced $5.35 quarterly dividend and the expanded buyback program (totaling $57.6M) create a steady bid for the stock.
- Strong credit quality: continued low charge-offs and stable loan performance would reassure investors and support multiple expansion.
- Any formal listing upgrade or increased analyst coverage could improve liquidity and investor interest.
Trade plan (actionable)
Entry: $1349.99 (current market).
Stop loss: $1200.00 (hard stop to protect capital against a deep weakness or a liquidity-driven gap).
Target: $1600.00 (single target to take profits into the first material resistance zone).
Horizon: long term (180 trading days) - this trade is intended to capture quarterly earnings cadence, dividend payments and buyback execution over the next several quarters. Expect the position to be held through at least one quarterly report and potentially longer if buybacks and dividends continue.
Position sizing notes: given the OTC listing and low daily volume, treat this as a smaller-sized position within a diversified portfolio. Use limit orders to avoid wide spreads and be prepared for slippage.
Risks and counterarguments
- Liquidity and execution risk. Average daily volumes are tiny; today's volume of 66 shares highlights the potential for large intraday gaps. That makes precise execution and stop placement more challenging.
- Macro/regional bank sensitivity. Although credit quality is reported as strong, regional banks remain sensitive to interest-rate moves, deposit flight and local economic shocks. A sharp downturn could pressure earnings and the dividend.
- Dividend and buyback dependency. A key part of the bull case is cash returned to shareholders. If earnings weaken materially, the bank may be forced to pause buybacks or slow dividend increases, hurting sentiment.
- Technical pullback risk. Momentum indicators are extended (RSI ~69), and the MACD histogram shows a small bearish reading. A short-term correction toward the 20-50 day averages is plausible before resuming an uptrend.
- Valuation and concentrated exposure. While the P/E looks reasonable, the company is a small-cap OTC name with limited float, which can produce volatile performance and put a premium on timing.
Counterargument: One could argue that the stock is vulnerable to a technical unwind or macro shock — the thin float can amplify downside moves, and a few missed loans or weaker-than-expected guidance could trigger a reevaluation by the market. If you expect a tougher credit environment, this trade may be too exposed.
What would change my mind
I would downgrade the trade if the bank reports a meaningful deterioration in asset quality, sizable charge-offs, or cuts to the dividend or buyback program. Conversely, if quarterly results accelerate meaningfully above current trends, or management increases the buyback authorization further, I would consider raising the target and tightening the stop.
Conclusion and stance
FMCB is a pragmatic long idea for investors who want conservative bank exposure blended with shareholder returns. The stock's 2025 earnings and Q1 2026 results provide a stable earnings base, the dividend history is rare and compelling, and the enlarged buyback program is a direct lever for shareholder value. At $1349.99, the shares trade at an attractive multiple versus reported EPS and offer a reasonable risk-reward for a long-term tactical position with a protective stop.
If you take the trade, size it modestly to reflect liquidity constraints and be ready to act if the earnings picture shifts. The plan: buy at $1349.99, protect at $1200.00, and take profits at $1600.00 within a long-term (180 trading days) window unless fresh information requires adjusting the plan.